SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-23-000010
Filing Date
2023-01-11
Accepted
2023-01-11 20:32:15
Documents
2
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167348711761914.html 4  
1 FORM 4 wf-form4_167348711761914.xml 4 5692
2 EXHIBIT 24 - MURRAY POWER OF ATTORNEY ex-24.htm EX-24 4583
  Complete submission text file 0001640455-23-000010.txt   11609
Mailing Address 22643 WOODRIDGE CT CUPERTINO CA 95014
Business Address
MURRAY RICHARD /CA/ (Reporting) CIK: 0001242935 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 23524701

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)